Angiogenesis in B-cell chronic lymphocytic leukemia: Methods of study, clinical significance and prognostic implications

Leukemia and Lymphoma

Volumn 42, Issue 4, 2001, Pages 603-607

  Molica, S ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Angiogenesis; CLL; Prognosis; VEGF

Indexed keywords

ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165;

ANGIOGENESIS; ARTICLE; B CELL LEUKEMIA; BLOOD DISEASE; BLOOD LEVEL; BONE MARROW; CANCER GRADING; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DENSITY; DISEASE COURSE; DISEASE MARKER; EVALUATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALIGNANT NEOPLASTIC DISEASE; METHODOLOGY; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0034861915     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109099320     Document Type: Article

References (24)

1. Angigenesis in cancer, vascular, rheumatoid and other disease
2. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
3. Primary structure of bovine fibroblastic growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acid FGF
4. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats
5. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
6. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
7. Evidence of increased angiogenesis in the bone marrow with acute non-lymphocytic leucemia
8. Evidence of increased angiogenesis in patients with acute myeloid leukaemia
9. Clinical relevance of vascular endothelial growth factor levels in B-cell chronic lymphocytic leukaemia
10. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia
11. Angiogenesis in acute and chronic leukaemia and myelodysplastic syndromes
12. In vitro and in vivo production of vascular endothelial growth factor chronic lymphocytic leukaemia cells
13. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
14. Angiogenesis and angiogenetic mediators in haematological maligniances
15. CD34 a Review
16. Elevated intracellular levels of basic fibroblastic growth factor correlate with stage of chronic lymphocytic leukaemia and is associated with resistance to fludarabine
17. Basic fibroblastic growth factor (b-FGF) upregulates the expression of bcl-2 in B-cell chronic lymphocytic leukaemia cell lines resulting in delaying apoptosis
18. Quantitative analysis of vascular endothelial growth expression in chronic lymphocytic leukaemia
19. Expression of vascular endothelial growth factor in lymphomas and Castelman's disease
20. Vascular endothelial growth factor isoforms 121 and 165 are expressed on B-chronic lymphocytic leukaemia
21. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
22. A high pretreatment serum basic fibroblastic growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
23. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: A single-institutions study of 200 patients
24. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor as predictor disease-progression in early B-cell chronic lymphocytic leukaemia